Latest AI and machine learning research in vaccines for healthcare professionals.
T-cells play a key role in adaptive immunity by mounting specific responses against diverse pathogen...
T-cell immunogenicity, the ability of peptide fragments to elicit T-cell responses, is a critical de...
Extracellular vesicles (EVs) are lipid-delineated nanoparticles that are produced by most cell types...
Polygenic Risk Scores (PRS) are emerging tools for predicting an individual’s genetic risk for compl...
The discovery of therapeutic antibodies is a traditionally arduous process. Today, the lab-based pro...
Understanding the spatiotemporal dynamics of T-cell clones is a critical challenge in immunology and...
A target-specific bait dispenser is required for oral bait vaccination of the endangered Tasmanian d...
Current DNA damage repair (DDR) biomarkers employ binary classifications that fail to capture the mo...
Messenger ribonucleic acid (mRNA) vaccines represent a major advancement in synthetic biology, yet t...
Female genital tumors (FGTs), including ovarian, endometrial, and cervical cancers, pose a major glo...
Codon sequence design is crucial for generating mRNA sequences with desired functional properties fo...
Therapeutic antibody design is a complex multi-property optimization problem with substantial promis...
Designing effective vaccination strategies against genetically diverse viruses, such as HIV or influ...
Although therapeutic drugs targeting gasdermin (GSDM)-mediated pyroptosis have made remarkable progr...
SARS-CoV-2 continues to spread over the world steadily as opposed to many earlier estimations that i...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
VHH discovery traditionally relies on animal immunization or large-scale library screening, methods ...
mRNA design plays a central role in synthetic biology, nucleic acid therapeutics, and vaccine develo...
The selection of an effective adjuvant is a critical bottleneck in vaccine development, particularly...
Molecular heterogeneity in head and neck squamous cell carcinoma (HNSCC) is well recognized, yet exi...